Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRPX - Virpax Pharmaceuticals Inc


Previous close
0.8072
0   0%

Share volume: 70,380
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$0.81
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-4.38%
1 Month
-27.21%
3 Months
12.07%
6 Months
-74.32%
1 Year
-90.93%
2 Year
-93.73%
Key data
Stock price
$0.81
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.46 - $9.00
52 WEEK CHANGE
-$0.91
MARKET CAP 
3.984 M
YIELD 
N/A
SHARES OUTSTANDING 
4.888 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$233,020
AVERAGE 30 VOLUME 
$465,422
Company detail
CEO:
Region: US
Website: virpaxpharma.com
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

virpax pharmaceuticals specializes in developing new drug delivery systems across various indications to increase compliance and maximize the ability to achieve full therapeutic efficacy. we develop branded pharmaceutical products for pain management by using cutting-edge technology to enhance patients'​ quality of life, all while creating value for our investors and partners. we are focused on becoming a global leader in non-opioid pain management by developing and delivering innovative pharmaceutical products to our customers. virpax is committed to collaborating with its network of u.s. and global partners to advance the development of proprietary drug platforms that will produce the next generation of branded pharmaceutical products.

Recent news